Related references
Note: Only part of the references are listed.Structure basis of neutralization by a novel site II/IV antibody against respiratory syncytial virus fusion protein
Qingqing Xie et al.
PLOS ONE (2019)
Transient opening of trimeric prefusion RSV F proteins
Morgan S. A. Gilman et al.
NATURE COMMUNICATIONS (2019)
A Potent Neutralizing Site III-Specific Human Antibody Neutralizes Human Metapneumovirus In Vivo
Yael Bar-Peled et al.
JOURNAL OF VIROLOGY (2019)
Alternative conformations of a major antigenic site on RSV F
Harrison G. Jones et al.
PLOS PATHOGENS (2019)
Characterization of potent RSV neutralizing antibodies isolated from human memory B cells and identification of diverse RSV/hMPV cross-neutralizing epitopes
Xiao Xiao et al.
MABS (2019)
A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein
Aimin Tang et al.
NATURE COMMUNICATIONS (2019)
Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation
Eileen Goodwin et al.
IMMUNITY (2018)
Delivery of ALX-0171 by inhalation greatly reduces respiratory syncytial virus disease in newborn lambs
Alejandro Larios Mora et al.
MABS (2018)
Safety, Tolerability and Pharmacokinetics of MEDI8897, an Extended Half-life Single-dose Respiratory Syncytial Virus Prefusion F-targeting Monoclonal Antibody Administered as a Single Dose to Healthy Preterm Infants
Joseph B. Domachowske et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2018)
Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins
Jarrod J. Mousa et al.
PLOS PATHOGENS (2018)
Structural basis for recognition of the central conserved region of RSV G by neutralizing human antibodies
Harrison G. Jones et al.
PLOS PATHOGENS (2018)
Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4
Guillaume B. E. Stewart-Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Detection of Airborne Respiratory Syncytial Virus in a Pediatric Acute Care Clinic
Stephanie A. Grayson et al.
PEDIATRIC PULMONOLOGY (2017)
Human Metapneumovirus Infection in Chronic Obstructive Pulmonary Disease: Impact of Glucocorticosteroids and Interferon
Keiko Kan-o et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Effectiveness of Palivizumab in High-risk Infants and Children A Propensity Score Weighted Regression Analysis
Evan J. Anderson et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2017)
A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants
Qing Zhu et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Structural, antigenic and immunogenic features of respiratory syncytial virus glycoproteins relevant for vaccine development
Jose A. Melero et al.
VACCINE (2017)
Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state (vol 8, 14158, 2017)
Iebe Rossey et al.
NATURE COMMUNICATIONS (2017)
Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein
Daiyin Tian et al.
NATURE COMMUNICATIONS (2017)
Structure and immunogenicity of pre-fusion-stabilized human metapneumovirus F glycoprotein
Michael B. Battles et al.
NATURE COMMUNICATIONS (2017)
A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein
Jarrod J. Mousa et al.
NATURE MICROBIOLOGY (2017)
Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus
Xiaolin Wen et al.
NATURE MICROBIOLOGY (2017)
Protection of calves by a prefusion-stabilized bovine RSV F vaccine
Baoshan Zhang et al.
NPJ VACCINES (2017)
Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection
Laurent Detalle et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Human metapneumovirus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review
Dimpy P. Shah et al.
CANCER LETTERS (2016)
Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein
Jarrod J. Mousa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Advances in RSV vaccine research and development - A global agenda
Deborah Higgins et al.
VACCINE (2016)
Engineering, Structure and Immunogenicity of the Human Metapneumovirus F Protein in the Postfusion Conformation
Vicente Mas et al.
PLOS PATHOGENS (2016)
Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors
Morgan S. A. Gilman et al.
SCIENCE IMMUNOLOGY (2016)
An Epitope-Specific Respiratory Syncytial Virus Vaccine Based on an Antibody Scaffold
Xiaozhou Luo et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera
Joan O. Ngwuta et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism
Anders Krarup et al.
NATURE COMMUNICATIONS (2015)
Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein
Morgan S. A. Gilman et al.
PLOS PATHOGENS (2015)
Human metapneumovirus: review of an important respiratory pathogen
Swagatika Panda et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2014)
Proof of principle for epitope-focused vaccine design
Bruno E. Correia et al.
NATURE (2014)
Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion protein
John T. Bates et al.
VIROLOGY (2014)
Cross-neutralization of four paramyxoviruses by a human monoclonal antibody
Davide Corti et al.
NATURE (2013)
Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody
Jason S. McLellan et al.
SCIENCE (2013)
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
Jason S. McLellan et al.
SCIENCE (2013)
Fatal human metapneumovirus infection following allogeneic hematopoietic stem cell transplantation
C. Dokos et al.
TRANSPLANT INFECTIOUS DISEASE (2013)
RSV hospitalisation and healthcare utilisation in moderately prematurely born infants
Deena Shefali-Patel et al.
EUROPEAN JOURNAL OF PEDIATRICS (2012)
Structure of the human metapneumovirus fusion protein with neutralizing antibody identifies a pneumovirus antigenic site
Xiaolin Wen et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
Respiratory Syncytial Virus Fusion Glycoprotein Expressed in Insect Cells Form Protein Nanoparticles That Induce Protective Immunity in Cotton Rats
Gale Smith et al.
PLOS ONE (2012)
Structure of Respiratory Syncytial Virus Fusion Glycoprotein in the Postfusion Conformation Reveals Preservation of Neutralizing Epitopes
Jason S. McLellan et al.
JOURNAL OF VIROLOGY (2011)
Llama-Derived Single Domain Antibodies to Build Multivalent, Superpotent and Broadened Neutralizing Anti-Viral Molecules
Anna Hultberg et al.
PLOS ONE (2011)
Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers
Kurt A. Swanson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Prophylactic and therapeutic benefits of a monoclonal antibody against the fusion protein of human metapneumovirus in a mouse model
Marie-Eve Hamelin et al.
ANTIVIRAL RESEARCH (2010)
Viral Pathogens Including Human Metapneumovirus Are the Primary Cause of Febrile Respiratory Illness in HIV-Infected Adults Receiving Antiretroviral Therapy
Marina B. Klein et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Structure of a Major Antigenic Site on the Respiratory Syncytial Virus Fusion Glycoprotein in Complex with Neutralizing Antibody 101F
Jason S. McLellan et al.
JOURNAL OF VIROLOGY (2010)
Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming
Mark J. Kwakkenbos et al.
NATURE MEDICINE (2010)
Structural basis of respiratory syncytial virus neutralization by motavizumab
Jason S. McLellan et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Humoral immunity to human metapneumovirus infection in adults
Ann R. Falsey et al.
VACCINE (2010)
Human metapneumovirus and respiratory syncytial virus: subtle differences but comparable severity
Nour Akhras et al.
INFECTIOUS DISEASE REPORTS (2010)
The Burden of Respiratory Syncytial Virus Infection in Young Children
Caroline Breese Hall et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Structures and Mechanisms of Viral Membrane Fusion Proteins: Multiple Variations on a Common Theme
Judith M. White et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2008)
Identification of antibody neutralization epitopes on the fusion protein of human metapneumovirus
Nancy D. Ulbrandt et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Characterization of the epitope for anti-human respiratory syncytial virus F protein monoclonal antibody 101F using synthetic peptides and genetic approaches
Sheng-Jiun Wu et al.
JOURNAL OF GENERAL VIROLOGY (2007)
A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo
John V. Williams et al.
JOURNAL OF VIROLOGY (2007)
Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract
Herren Wu et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Characterization of human metapneumovirus F protein-promoted membrane fusion: Critical roles for proteolytic processing and low pH
Rachel M. Schowalter et al.
JOURNAL OF VIROLOGY (2006)
Isolation and characterization of monoclonal antibodies which neutralize human Metapneumovirus in vitro and in vivo
Nancy D. Ulbrandt et al.
JOURNAL OF VIROLOGY (2006)
Brief communication: Fatal human metapneumovirus infection in stem-cell transplant recipients
JA Englund et al.
ANNALS OF INTERNAL MEDICINE (2006)
Individual contributions of the human metapneumovirus F, G, and SH surface glycoproteins to the induction of neutralizing antibodies and protective immunity
MH Skiadopoulos et al.
VIROLOGY (2006)
Human metapneumovirus infection in lung transplant recipients:: Clinical presentation and epidemiology
C Larcher et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2005)
Human metapneumovirus-associated lower respiratory tract infections among hospitalized human immunodeficiency virus type 1 (HIV-1)-infected and HIV-1-uninfected African infants
SA Madhi et al.
CLINICAL INFECTIOUS DISEASES (2003)
Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients
BG van den Hoogen et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Human metapneumovirus infections in young and elderly adults
AR Falsey et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Human metapneumovirus in a haematopoietic stem cell transplant recipient with fatal lower respiratory tract disease
PA Cane et al.
BONE MARROW TRANSPLANTATION (2003)
A newly discovered human pneumovirus isolated from young children with respiratory tract disease
BG van den Hoogen et al.
NATURE MEDICINE (2001)
Share Paper
